Table 3 Subgroup analysis of intima-media thickening and atherosclerotic plaques in systemic sclerosis and systemic lupus erythematosus patients with cardiovascular disease
Subgroup of SSc and SLE patients with cardiovascular disease | Pathologic IMT (any definition) | Atherosclerotic plaque | ||||
|---|---|---|---|---|---|---|
Carotid and/or femoral artery plaque | Only carotid artery plaque | Only femoral artery plaque | Coexistent carotid and femoral artery plaque | |||
SSc patients with | Arterial hypertension (n = 45) | 16 (35.6%) | 38 (84.4%) | 7 (15.6%) | 5 (11.1%) | 26 (57.8%) |
Pulmonary hypertension (n = 17) | 6 (35.3%) | 15 (88.2%) | 0 (0%) | 2 (11.8%) | 13 (76.5%) | |
Coronary heart disease (n = 10) | 2 (20%) | 8 (80%) | 0 (0%) | 0 (0%) | 8 (80%) | |
Peripheral artery vessel disease (n = 5) | 2 (40%) | 4 (80%) | 1 (20%) | 1 (20%) | 2 (40%) | |
SLE patients with | Arterial hypertension (n = 56) | 15 (26.8%) | 39 (69.6%) | 10 (17.9%) | 9 (16.1%) | 20 (35.7%) |
Pulmonary hypertension (n = 3) | 1 (33.3%) | 3 (100%) | 1 (33.3%) | 1 (33.3%) | 1 (33.3%) | |
Coronary heart disease (n = 9) | 5 (55.6%) | 9 (100%) | 1 (11.1%) | 0 (0%) | 8 (88.9%) | |
Peripheral artery vessel disease (n = 2) | 1 (50%) | 2 (100%) | 0 (0%) | 0 (0%) | 2 (100%) | |